Double Modulation of 5-Fluorouracil in the Treatment of Advanced Colorectal Carcinoma: Report of a Trial with Sequential Methotrexate, Intravenous (Loading Dose) Folinic Acid, 5-Fluorouracil, and a Literature Review

References

• Laufman L R, Krzeczowski K A, Roach R, et al. Leucovorin plus 5-fluorouracil: An effective treatment for metastatic colon cancer. J Clin Oncol 1987; 5: 1394–1400
   PubMed Web of Science ®Google Scholar
• Byrne P, Smith F, Treat J, et al. 5-Fluorouracil and higher dose folinic acid treatment of colorectal carcinoma patients. Proc Am Soc Clin Oncol 1983; 2: 121, (abstract)
   Google Scholar
• Budd G T, Fleming T R, Bukowski R M, et al. 5-Fluorouracil and folinic acid in the treatment of metastatic colorectal cancer: A randomized comparison. A Southwest Oncology Group study. J Clin Oncol 1987; 5: 272–277
   PubMed Web of Science ®Google Scholar
• Madajewicz S., Petrelli N F, Rustum Y M, et al. A phase I-II trial of high dose calcium leucovorin and 5-fluorouracil in advanced colorectal cancer. Cancer Res 1984; 44: 4667–4669
   PubMed Web of Science ®Google Scholar
• Machover D, Goldschmidt E, Chollet P, et al. Treatment of advanced colorectal and gastric adenocarcinoma with 5-fluorouracil and high-dose folinic acid. J. Clin Oncol 1986; 4: 685–696
   Web of Science ®Google Scholar
• Kemeny N, Michaelson R. Phase II trial of low dose methotrexate and sequential 5-fluorouracil in the treatment of metastatic colorectal carcinoma. Proc Am Soc Clin Oncol 1982; 1: 95, (abstract)
   Google Scholar
• Weinerman B, Schacter B, Schipper H, et al. Sequential methotrexate and 5-FU in the treatment of colorectal cancer. Cancer Treat Rep 1982; 66: 1553–1555
   PubMedGoogle Scholar
• Nordic Gastrointestinal Tumor Adjuvant Therapy Group. Superiority of sequential methotrexate, fluorouracil, and leucovorin to fluorouracil alone in advanced symptomatic colorectal carcinoma: A randomized trial. J Clin Oncol 1989; 7: 1437–1446
   PubMed Web of Science ®Google Scholar
• Wadler S, Schwartz E L, Goldman M, et al. Fluorouracil and recombinant alfa-2a-interferon: An active regimen against advanced colorectal carcinoma. J Clin Oncol 1989; 7: 1769–1775
   PubMed Web of Science ®Google Scholar
• Pazdur R, Ajani J A, Patt Y Z, et al. Phase II study of fluorouracil and recombinant interferon alfa-2a in previously untreated advanced colorectal carcinoma. J Clin Oncol 1990; 8: 2027–2031
   PubMed Web of Science ®Google Scholar
• Grem J L. Biochemical modulation of fluororuracil by dipyridamole: Preclinical and clinical experience. Semin Oncol 1992; 19(Suppl 3)56–65
   PubMedGoogle Scholar
• Ardalan B, Singh G, Silberman H. A randomized phase I and II study of short-term infusion of high-dose fluorouracil with or without N-(phosphonacetyl)-L-aspartic acid in patients with advanced pancreatic and colorectal cancers. J Clin Oncol 1988; 6: 1053–1058
   PubMed Web of Science ®Google Scholar
• O'Dwyer P J, Paul A R, Walczak J, et al. Phase II study of biochemical modulation of fluorouracil by low-dose PALA in patients with colorectal cancer. J Clin Oncol 1990; 8: 1497–1503
   PubMed Web of Science ®Google Scholar
• Poon M A, O'Connell M J, Moertel C G, et al. Biochemical modulation of fluorouracil: Evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma. J Clin Oncol 1989; 7: 1407–1417
   PubMed Web of Science ®Google Scholar
• Poon M A, O'Connell M J, Wieand H S, et al. Biochemical modulation of fluorouracil with leucovorin: Confirmatory evidence of improved therapeutic efficacy in advanced colorectal cancer. J Clin Oncol 1991; 9: 1967–1972
   PubMed Web of Science ®Google Scholar
• Ignoffo R J, Friedman M A, Gribble M, et al. Phase II study of sequential methotrexate and 5-FU plus mitomycin and leucovorin in patients with disseminated large bowel cancer: A Northern California Oncology Group Study. Cancer Treat Rep 1984; 68: 983–988
   PubMedGoogle Scholar
• Marsh J C, Bertino J R, Katz K H, et al. The influence of drug interval on the effect of methotrexate and fluorouracil in the treatment of advanced colorectal cancer. J Clin Oncol 1991; 9: 371–380
   PubMed Web of Science ®Google Scholar
• Miller A B, Hoogstraten B, Staquet M, et al. Reporting results of cancer treatment. Cancer 1981; 47: 207–214
   PubMed Web of Science ®Google Scholar
• Arbuck S G. 5-FU/leucovorin: Biochemical modulation that works?. Oncology 1987; 1(2)61–71
   PubMedGoogle Scholar
• Moran R G. Leucovorin enhancement of the effects of the fluoropyrimidines on thymidylate synthase. Cancer 1989; 63: 1008–1012
   PubMed Web of Science ®Google Scholar
• Erlichman C, Fine S, Wong A, et al. A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma. J Clin Oncol 1988; 6: 469–475
   PubMed Web of Science ®Google Scholar
• Petrelli N, Douglass H O, Herrera L, et al. The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: A prospective randomized phase III trial. J Clin Oncol 1989; 7: 1419–1426
   PubMed Web of Science ®Google Scholar
• Doroshow J H, Multhauf P, Leong L, et al. Prospective randomized comparison of fluorouracil versus fluorouracil and high-dose continuous infusion leucovorin calcium for the treatment of advanced measurable colorectal cancer in patients previously un-exposed to chemotherapy. J Clin Oncol 1990; 8: 491–501
   PubMed Web of Science ®Google Scholar
• Petrelli N, Herrera L, Rustum Y, et al. A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leucovorin versus 5-fluorouracil and methotrexate in previously un-treated patients with advanced colorectal carcinoma. J Clin Oncol 1987; 5: 1559–1565
   PubMed Web of Science ®Google Scholar
• Valone F H, Friedman M A, Wittlinger P S, et al. Treatment of patients with advanced colorectal carcinomas with fluorouracil alone, high-dose leucovorin plus fluorouracil, or sequential methotrexate, fluorouracil, and leucovorin: A randomized trial of the Northern California Oncology Group. J Clin Oncol 1989; 7: 1427–1436
   PubMed Web of Science ®Google Scholar
• Bertino J R, Mini E, Fernandes D J. Sequential methotrexate and 5-fluorouracil: Mechanisms of synergy. Semin Oncol 1983; 10(Suppl 2)2–5
   PubMed Web of Science ®Google Scholar
• Wadler S, Schwartz E L. Principles in the biomodulations of cytotoxic drugs by interferons. Semin Oncol 1992; 19(Suppl 3)45–48
   PubMedGoogle Scholar
• Danhauser L L, Heimer R, Cadman E. Lack of enhanced cytotoxicity of cultured L1210 cells using folinic acid in combination with sequential methotrexate and fluorouracil. Cancer Chemother Pharmacol 1985; 15: 214–219
   PubMed Web of Science ®Google Scholar
• Romanini A, Bertino J R. Leucovorin effects on sequential methotrexate or trimetrexate-5-fluorouracil cytotoxicity. Proc Am Assoc Cancer Res 1990; 31: 389
   Google Scholar
• Abad A, Rosell R, Pastor M C, et al. Sequential combination of methotrexate (MTX), 5-fluorouracil (FU), and high-dose folinic acid (FA) in advanced colorectal cancer: Double biochemical modulation?. Am J Clin Oncol 1991; 14: 393–396
   PubMed Web of Science ®Google Scholar
• Bukowski R M, Inoshita G, Yalavarthi P, et al. A phase I trial of 5-fluorouracil, folinic acid, and alpha-2a-interferon in patients with metastatic colorectal carcinoma. Cancer 1992; 69: 889–892
   PubMed Web of Science ®Google Scholar
• Zaniboni A, Marpicati P, Simoncini E, et al. Fluorouracil, high-dose folinic acid, low-dose alpha-2b interferon and dipyridamole in the treatment of advanced colorectal cancer. A pilot study. J Chemother 1991; 3: 180–182
   PubMed Web of Science ®Google Scholar
• Fountzilas G, Zisiadis A., Kosmidis P, et al. High-dose leucovorin, fluorouracil and oral dipyridamole in the treatment of advanced colorectal cancer. Anticancer Res 1991; 11: 865–868
   PubMed Web of Science ®Google Scholar
• Preiss J. Fluorouracil plus interferon + folinic acid in regional and systemic therapy in colorectal cancer. Semin Oncol 1992; 19(Suppl 3)220–224
   PubMedGoogle Scholar
• Punt C JA, de Mulder P HM, Burghouts J ThM, et al. Fluorouracil continuous infusion plus alfa interferon plus oral folinic acid in advanced colorectal cancer. Semin Oncol 1992; 19(Suppl 3)208–210
   PubMedGoogle Scholar
• Grem J L, Chu E, Boarman D, et al. Biochemical modulation of fluorouracil with leucovorin and interferon: Preclinical and clinical investigations. Semin Oncol 1992; 19(Suppl 3)36–44
   PubMedGoogle Scholar
• Schmoll H J, Kohne-Wömpner C H, Hiddemann W, et al. Interferon alpha-2b, 5-fluorouracil, and folinic acid combination therapy in advanced colorectal cancer: Preliminary results of a phase I/II trial. Semin Oncol 1992; 19(Suppl 3)191–196
   PubMedGoogle Scholar